Cerecor, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of prescription pharmaceuticals. The company focuses on human brain and nervous system. Its products include translational medicines, products for cough, and inhibitors for schizophrenia. The company was incorporated in 2011 and is based in Baltimore, Maryland.